PT - JOURNAL ARTICLE AU - Tedeschi, Elisa AU - Menegazzi, Marta AU - Margotto, Daniela AU - Suzuki, Hisanori AU - Förstermann, Ulrich AU - Kleinert, Hartmut TI - Anti-Inflammatory Actions of St. John's Wort: Inhibition of Human Inducible Nitric-Oxide Synthase Expression by Down-Regulating Signal Transducer and Activator of Transcription-1α (STAT-1α) Activation AID - 10.1124/jpet.103.054460 DP - 2003 Oct 01 TA - Journal of Pharmacology and Experimental Therapeutics PG - 254--261 VI - 307 IP - 1 4099 - http://jpet.aspetjournals.org/content/307/1/254.short 4100 - http://jpet.aspetjournals.org/content/307/1/254.full SO - J Pharmacol Exp Ther2003 Oct 01; 307 AB - St. John's wort (SJW) has been described to show anti-inflammatory properties due to its inhibitory effects on the expression of pro-inflammatory genes like cyclooxygenase-2, interleukin-6, and inducible nitric-oxide synthase (iNOS). Since iNOS plays a critical role in chronic inflammatory diseases, we have focused our attention on the regulation of iNOS expression by SJW in two different human epithelial cell lines, alveolar A549/8 and colon DLD-1 cells. SJW extract concentration dependently inhibited human iNOS expression evaluated by measuring the amounts of iNOS mRNA, iNOS protein, and NO production in both cell lines. This inhibitory effect resulted from transcriptional inhibition as shown in reporter gene experiments. With electrophoretic mobility shift experiments, we found a SJW-mediated down-regulation of the DNA binding activity of the transcription factor signal transducer and activator of transcription-1α (STAT-1α), but not of nuclear factor-κB. This down-regulation of the STAT-1α DNA binding was shown to result from reduced tyrosine phosphorylation of the STAT-1α protein. The diminished STAT-1α tyrosine phosphorylation resulted from SJW-mediated reduction of Janus kinase 2 activity. These data suggest that extracts from SJW may be a promising anti-inflammatory principle in chronic inflammatory diseases. The American Society for Pharmacology and Experimental Therapeutics